Raul Parra Jr. - Mar 5, 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CFO AND TREASURER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Mar 5, 2025
Transactions value $
-$353,129
Form type
4
Date filed
3/6/2025, 05:39 PM
Previous filing
Mar 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $202K +5.36K +22.15% $37.71 29.6K Mar 5, 2025 Direct
transaction MMSI Common Stock, No Par Value Sale -$555K -5.36K -18.13% $103.58 24.2K Mar 5, 2025 Direct F2
holding MMSI Common Stock, No Par Value 2.77K Mar 5, 2025 By 401(k) Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -5.36K -100% $0.00 0 Mar 5, 2025 Common Stock 5.36K $37.71 Direct F3
holding MMSI Non-qualified stock options (right to buy) 9.68K Mar 5, 2025 Common Stock 9.68K $56.25 Direct F4
holding MMSI Non-qualified stock options (right to buy) 14.6K Mar 5, 2025 Common Stock 14.6K $65.03 Direct F5
holding MMSI Non-qualified stock options (right to buy) 13.6K Mar 5, 2025 Common Stock 13.6K $70.58 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents plan holdings as of 2/28/2025.
F2 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.695, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.
F4 Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
F5 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
F6 Becomes exercisable in equal annual installments of 25% commencing 02/28/2024.